Can value-based care transform the American healthcare system? In this episode, we dive deep into this pressing question with Dr. Mohamed Diab, president of CVS Accountable Care. Dr. Diab highlights systemic challenges, such as physician burnout and the inadequacies of primary care funding. With an emphasis on primary care's critical role in managing chronic conditions and preventing illness, he reveals how a shift to value-based care can lead to better health outcomes by focusing on holistic, patient-centered approaches that tackle social determinants and behavioral health.

We also address the complexities of this transition, specifically for healthcare executives who are navigating the shift from fee-for-service to value-based models. Learn about Medicare's ambitious plan to achieve 100% value-based care by 2030 and discover how CVS Health's Accountable Care Organization is leveraging technology, analytics, and clinical programs to support providers and Medicare beneficiaries.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Greg Mario, CEO of TAXIS Pharmaceuticals shares his dynamic journey from a childhood of constant relocations to spearheading the fight against antibiotic-resistant infections. Greg opens up about his immigrant grandparents' profound influence and a transformative experience with a captivating professor at Trinity College that shifted his academic focus from mechanical engineering to chemistry. This pivotal change set the foundation for his career in the pharmaceutical industry, highlighting his adaptability and dedication to human health.

Discover the fascinating evolution of Evogen, a company initially centered on bio and chemical threat detection, which pivoted to tackle central nervous system diseases under Greg's leadership. We also explore the creation of as revolutionary blood-based epilepsy diagnostic test, as well as the pressing issue of antibiotic resistance.

Greg provides a historical perspective on antibiotics and underscores the urgent need for innovative antimicrobial treatments to combat the relentless rise of superbugs, emphasizing the resilience and adaptability required in the healthcare industry.

In the final section, we explore the relentless pursuit of funding in the biotech world through Greg's experiences with TAXIS Pharmaceuticals. Learn about the company's early days and the recent $2.7 million NIH grant for their promising efflux pump inhibitor, now on the brink of human trials.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Unlock the secrets to effective behavioral health management in long-term care in this interview with Rocco Coniglio, a powerhouse in healthcare entrepreneurship. From a sports-driven childhood in Pittsburgh to collegiate triumphs as a middle linebacker, Rocco's journey is certain to inspire. We dive into his career, navigating roles at McKesson, Gambro, Medtronic, and Spectranetics, and explore his bold move to co-found Psych360 mid-career. Get actionable insights on starting a business while juggling a high-stakes job and learn why a supportive company culture is pivotal for success.

The second half of the episode delves into the complex world of nursing home regulations and the transformative role of telehealth. Discover how CMS rules reshaped medication practices and learn about the importance of advanced practice nurses in long-term care.

We also discuss strategic partnerships with universities to tackle psychiatrist shortages and the game-changing impact of telehealth, especially in rural areas. Tune in for a comprehensive look at the future of healthcare, featuring expert opinions on trends, challenges, and innovative strategies for better health outcomes and operational efficiency.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Listen in to this informative episode with Pete O'Heeron, CEO of FibroBiologics, as we explore his journey from a small, innovative town to the forefront of healthcare innovation. Pete shares how his upbringing in a medically inclined family and a community rich with inventiveness influenced his career. Hear how Pete transitioned from pre-med to hospital administration due to unforeseen geopolitical events, ultimately finding his passion within the healthcare industry.

Pete recounts his transformative experience at Christus, a multi-billion dollar hospital system, where his pivot from hospital administration to product development led to significant advancements in surgical instruments and an impressive return for shareholders.

We delve into the revolutionary potential of fibroblasts, often overshadowed by stem cells, and their efficacy in regenerating tissue and treating chronic diseases. Pete explains how innovative techniques in fibrogenesis, such as applying pressure in low oxygen environments, can turn dermal fibroblasts into cartilage-type cells, opening new therapeutic avenues.

We also cover the exciting advancements in fibroblast research and its applications across various medical fields. Highlighting the influence of Nobel Prize winners like Jim Allison and Jennifer Doudna, Pete discusses the promising results seen in wound care, multiple sclerosis, degenerative diseases, and more. With plans for upcoming clinical trials and commercialization strategies, Pete shares his admiration for influential figures like Elon Musk and reflects on the unique approaches to leadership in the biotech industry. Don't miss this engaging conversation filled with valuable insights into healthcare innovation and strategic partnerships.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

The future of healthcare isn't just about treating illness, but fundamentally reshaping how care is delivered and experienced. Join us as Emily Young from Tufts Medicine Integrated Network and Courtney Fortner from Navvis share their compelling insights on the transformative potential of value-based care. Emily delves into the importance of integrating value-based and volume-based approaches, while Courtney brings to light the inspirational story of a physician who found renewed purpose and postponed retirement thanks to the positive impact of value-based care.

Strategic partnerships and collaboration between payers and providers are crucial in accelerating the shift to value-based care. Emily and Courtney explore the intricacies of this journey, emphasizing the necessity for clinical and payment transformations to work in tandem. The discussion highlights how organizations like Tufts leverage market dynamics and strategic relationships to advance in value-based care, painting a vivid picture of a healthcare system poised for long-term, meaningful improvements.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

What if your dentist could spot cavities long before they became a problem? Join us as we chat with Jordan Rubinson, CEO of CaviSense, about his interesting journey from pharma to medtech We start by discussing Jordan's early influences, from his father's career at Block Drug Company to his own academic adventures at Columbia and MIT's Sloan School. Despite an initial interest in accounting, Jordan's passion for pharma led him down a path less traveled, avoiding the conventional business routes of consulting and investment banking.

Next, we take a closer look at Jordan's dynamic career in the pharmaceutical industry. Learn how his family's frequent relocations led to professional opportunities across the globe. Jordan shares anecdotes from his time in big pharma, including his experiences within a management development program at Sanofi Pasteur and the challenges of managing diverse roles in different markets. His shift from big pharma to the innovative medtech startup scene in Israel provides a compelling narrative about the contrasts between structured environments and the fast-paced, resource-tight nature of startups.

Finally, we explore the evolving role of dentists as both medical professionals and entrepreneurs. Discover how new technologies are revolutionizing dental care, especially in pediatric dentistry. Jordan introduces us to CaviSense, a groundbreaking tool for early cavity detection, and discusses its journey from early development to FDA registration. We also touch on the exciting future of consumer-friendly dental monitoring tools that could transform how we manage oral health at home.

Don't miss this episode to hear about the future of interactive dental care and the potential for improved patient outcomes.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Travis Morgan, President and CFO of DecisionRx touts medication optimization as the way to improve outcomes and reduce costs. In this episode, Travis shares his journey from an entrepreneurial upbringing to making waves in the life sciences and healthcare technology sectors. Learn how his experiences in public accounting and as a precision medicine company co-founder have shaped his unique approach to tackling one of the healthcare industry's most costly issues: ineffective medications.

Hear how DecisionRx is leveraging pharmacogenomics and data science to improve patient outcomes and reduce healthcare expenses. Travis explains the impact of pharmacist-led interventions , and how the value-based care model, combined with genetic analysis, can guides clinical decision to prevent medication failures. Get insights into the commercial success of this approach, particularly within risk-bearing entities like ACOs and Medicare Advantage plans.

Learn about the power of innovative medication optimization, eliminating the usual friction associated with third-party reimbursement. Travis discusses the company's scale-up effort, with over 230,000 lives under contract through accountable care organizations and substantial financial backing from the Carlyle Group.

Finally, hear why Travis recommends "Endurance: The Biography of Ernest Shackleton," as an essential read for any aspiring leader.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Curious about the forces driving healthcare pricing and access? Join us for an enlightening conversation with Sarah Emond, President and CEO of the Institute for Clinical and Economic Review (ICER). Sarah's upbringing in a family passionate about policy and social justice laid the foundation for her impactful career in health policy. We explore her educational journey from Smith College to Brandeis University’s Heller School, and how her professional experiences in clinical research and biopharmaceutical consulting shaped her path to ICER.

Unravel the complex world of health technology assessment (HTA) in the US as Sarah breaks down the challenges and opportunities within a fragmented healthcare system. ICER's pivotal role in evaluating new medical technologies is discussed in depth, including its interactions with international agencies like the UK's NICE. Sarah sheds light on ICER's evolution from a small initiative within Mass General Hospital to a powerful voice in global HTA practices, emphasizing the importance of fair pricing, patient access, and sustainable innovation funding.

Equity in healthcare takes center stage as Sarah introduces ICER’s updated value assessment framework. Learn about new tools like the clinical trial diversity rating and the Health Improvement Distribution Index (HIDI) designed to promote representation of diverse populations in clinical trials. We also tackle the high costs and value-based pricing of innovative treatments, including gene and cell therapies, and the necessity of evolving payment systems to ensure continuous innovation. Tune in to gain a comprehensive understanding of the pressing challenges and future directions in healthcare pricing, equity, and access.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.